Mammalian target of rapamycin complex 1 kinase (mTORC1)

Mammalian target of rapamycin complex 1 kinase (mTORC1) is a serine/threonine kinase at the heart of the mTOR signaling pathway, which regulates fundamental cellular processes including growth, proliferation, metabolism, autophagy, and survival. mTORC1 is activated in response to growth factors, nutrients, and energy signals, primarily phosphorylating downstream targets like S6K1 and 4E-BP1 to promote protein synthesis and cell cycle progression. ATP-competitive mTORC1 inhibitors are a class of small-molecule drugs that block the catalytic activity of mTORC1 (and frequently mTORC2) by occupying the ATP-binding pocket of the kinase. Unlike allosteric inhibitors (rapalogs) that only inhibit mTORC1, these ATP-competitive inhibitors suppress both complexes, disrupt oncogenic growth signals, and overcome some forms of drug resistance. Clinically, these drugs show promise but are associated with notable adverse events and complex feedback effects in signal transduction pathways.

Other names

mTORC1Mammalian target of rapamycin complex 1Mechanistic target of rapamycin complex 1

ATP-competitive inhibition: Drugs bind to the ATP-binding pocket of mTORC1 and block kinase activity by competing with ATP. Dual inhibition: Many ATP-competitive mTOR inhibitors also inhibit mTORC2, blocking feedback activation of PI3K/AKT signaling.